FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Bid/Ask 15:50:32 2024-06-11 EDT | ||
| 0.18 EUR | 0.00% |
|
| Current month | +28.57% | ||
| 1 month | -28.00% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-11 | 0.18 | 0.00% |
| 24-06-10 | 0.18 | +20.00% |
| 24-06-07 | 0.15 | +7.14% |
| 24-06-06 | 0.14 | -6.67% |
| 24-06-05 | 0.15 | -6.25% |
Real-time Boerse Frankfurt Warrants
Last update June 11, 2024 at 03:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB01XD |
| ISIN | DE000SB01XD9 |
| Date issued | 2020-06-09 |
| Strike | 61.27 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 8.86 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 15.62 € |
|---|---|
| Lowest since issue | 0.13 € |
| Spread | 0.01 € |
| Spread % | 5.26% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
42.57
USD
Average target price
53.19
USD
Spread / Average Target
+24.96%
- Stock Market
- Certificates
- Certificat
